Results 231 to 240 of about 32,023 (271)

Discovery of a novel 4-pyridyl SLC-0111 analog targeting tumor-associated carbonic anhydrase isoform IX through tail-based design approach with potent anticancer activity. [PDF]

Front Chem
Hashem H, Abdelfattah S, Hassan HM, Al-Emam A, Alqarni M, Alotaibi G, Radwan IT, Kaur K, Rao DP, Bräse S, Alkhammash A.   +10 more
europepmc   +1 more source

Cell-to-cell signalling mediated via CO₂: activity dependent CO₂production in the axonal node opens Cx32 in the Schwann cell paranode

Butler J, Mott L, Brown A, Dale N.
europepmc   +1 more source

Prescribing carbonic anhydrase inhibitors to patients with "sulfa" antibiotics allergy: do we dare? [PDF]

Eye (Lond)
Quintanilla R, van Leeuwen L, Sharma A, Chang TC, Hodapp E, McSoley J, Grajewski A, Bitrian E.   +7 more
europepmc   +1 more source

Electrocardiographic signs of cardiac ischemia at rest and during exercise in patients with COPD travelling to 3100 m. Data from a randomized trial of acetazolamide

Christen M, Buergin A, Mademilov M, Mayer L, Schneider SR, Lichtblau M, Sooronbaev TM, Ulrich S, Bloch KE, Furian M.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acetazolamide and Urolithiasis

Ophthalmology, 1981
Abstract: Interviews were conducted with 515 individuals between the ages of 20 and 80 years to gather data on acetazolamide therapy and the occurrence of urolithiasis. One hundred forty-eight patients were treated with chronic oral acetazolamide therapy for one week to 348 months (mean 40.9 months).
Bernard Becker, Michael A. Kass, Mae O. Gordon, Allan E. Kolker, Ivan Goldberg, D. K. Gieser, Theodore Krupin   +6 more
openaire   +3 more sources

Hemodialyzability of Acetazolamide

Southern Medical Journal, 1980
Because the dialyzability of acetazolamide is not known, we undertook a study to determine the in vivo dialysance of this drug and found it to average 22 ml per minute. The quantity of the drug removed by four hours of dialysis was approximately 30% of the dose administered intravenously one half hour before dialysis.
R. Ness, J. Saiki, Nosratola D. Vaziri, Cyril H. Barton, Rajudin M   +4 more
openaire   +3 more sources

Effects of acetazolamide on myotonia

Annals of Neurology, 1978
AbstractMyotonia can occur in the periodic paralyses, particularly the hyperkalemic form. The beneficial response to acetazolamide in hypokalemic and hyperkalemic periodic paralysis has led us to study the effect of acetazolamide in 9 patients with disorders having myotonia as the major problem, 7 with myotonia congenita and 2 with paramyotonia ...
Jack E. Riggs, Richard T. Moxley, W. King Engel, Robert C. Griggs   +3 more
openaire   +4 more sources

Acetazolamide-induced nephrocalcinosis

Abdominal Imaging, 1994
Nephrocalcinosis has been reported in patients treated with acetazolamide and other agents, such as furosemide or bicarbonate. We present a case of nephrocalcinosis induced solely by acetazolamide and diagnosed radiographically. Possible mechanisms of pathogenesis are reviewed.
Jay R. Parikh, Robert L. Nolan
openaire   +2 more sources

Acetazolamide and renal ammoniagenesis

American Journal of Physiology-Renal Physiology, 1978
The effect of acetazolamide on ammonia-producing enzyme systems was determined in vitro at concentrations comparable to those which have been shown to abolish ammonium excretion in vivo. No change in the activity of glutaminase or gamma-glutamyl transpeptidase could be observed at concentrations up to 0.2 mM acetazolamide, and concentrations up to 1 ...
M. S. Hoover, S. K. Chapman
openaire   +3 more sources